We previously reported a genome-wide association study (GWAS) identifying 14 susceptibility loci for generalized vitiligo. We report here a second GWAS (450 individuals with vitiligo (cases) and 3,182 controls), an independent replication study (1,440 cases and 1,316 controls) and a meta-analysis ( In generalized vitiligo, patches of depigmented skin and hair result from the autoimmune destruction of epidermal melanocytes 1 , which has been epidemiologically associated with other autoimmune diseases 2 . In previous linkage analyses and a GWAS (GWAS1; Supplementary  Table 1 ), we identified 14 replicated vitiligo susceptibility loci [3] [4] [5] in individuals of non-Hispanic European ancestry. Most of these loci encode immunoregulatory proteins, and several are associated with other autoimmune diseases. However, one, TYR, encodes tyrosinase, a key enzyme of melanin biosynthesis that likely mediates the immune targeting of melanocytes. Causal variation at TYR is inversely associated with vitiligo and malignant melanoma 6 , suggesting that vitiligo may be related to the immune surveillance of melanoma 7 .
To identify additional vitiligo susceptibility loci, we performed a second GWAS (GWAS2; Supplementary Table 1 ) and a metaanalysis of the GWAS1 and GWAS2 data to enhance statistical power. GWAS2 included 450 cases and genotype data from 3,182 controls, all of European ancestry, from the NCBI database of Genotypes and Phenotypes (dbGaP). Almost all of the genome-wide significant loci from GWAS1 showed an increase in the significance of their associations in the meta-analysis, as well as CCR6 (ref. 4) , which now achieves genome-wide significance ( Supplementary Table 2 ). We also identified suggestive associations (P < 10 −4 for multiple SNPs across a region) of 24 additional loci ( Supplementary Fig. 1 and Supplementary Table 3 ) in the meta-analysis, six of which achieved genome-wide significance (P < 5 × 10 −8 ) ( Table 1) . At all 24 newly implicated loci, we imputed genotypes using 1000 Genomes Project data, performed logistic regression to identify independent association signals and genotyped the most significant SNPs at each locus ( Supplementary Table 3 ) in an independent replication cohort of 1,440 cases and 1,316 controls, all of European ancestry. We then performed an overall meta-analysis of GWAS1, GWAS2 and the replication study data using the following conservative criteria for confirming association: (i) nominal association in the replication study (P < 0.05), (ii) consistent high-risk alleles in GWAS1, GWAS2 and the replication study, (iii) nonsignificant heterogeneity across all three studies (P > 1.09 × 10 −3 ) and (iv) overall combined genomewide significance (P < 5 × 10 −8 ). Table 1 , this combined meta-analysis identified 13 loci newly associated with vitiligo. Among the most noteworthy of these was at chromosome 15q12-q13.1, where the meta-analysis of the data from GWAS1 and GWAS2 showed suggestive associations of SNPs spanning OCA2 to upstream within HERC2 (nt 27,886,016-28,392,261) ( Fig. 1) , in particular, rs12913832 (P = 3.29 × 10 −7 ) and the imputed SNP rs1129038 (P = 3.23 × 10 −7 ) (r 2 = 0.99). OCA2 is causal for oculocutaneous albinism type 2, encodes a melanosomal membrane transporter 8 and has a major role in determining skin, hair and eye color. The replication study and overall meta-analysis confirmed the associations of both rs1129038 (P = 3.80 × 10 −8 , odds ratio (OR) = 1.22) and rs12913832 (P = 3.81 × 10 −8 , OR = 1.22) (Table 1) . Furthermore, the SNP alleles that are low risk for vitiligo are strongly associated with gray or blue eye color [9] [10] [11] and with an elevated risk of malignant melanoma 12, 13 , tagging a founder variant within HERC2 that downregulates transcription of the OCA2 allele in cis 11, 14 . OCA2 is thus analogous to TYR: both genes encode melanocyte antigens presented by HLA-A*02 (refs. 15,16) , in both genes, vitiligo protection is associated with reduced amounts of functional protein, and for both genes, susceptibility to vitiligo and melanoma constitute genetic opposites 7 , perhaps modulating immune surveillance for melanoma ( Supplementary Fig. 2 ). Furthermore, we predicted that, among patients with vitiligo, gray or blue eye color should be underrepresented, and tan or brown eye color should be over-represented. To test this, we surveyed 1,206 cases of European ancestry and confirmed both predictions: among patients with vitiligo, the prevalence of gray or blue eye color (26.8%) was much lower and the prevalence of tan or brown eye color (43.2%) was much higher compared to American 17 (P < 0.0001) and Australian 18 (P < 0.0001) individuals of European ancestry ( Table 2 ). Compared to persons with gray or blue eye color, the OR for vitiligo was 2.98 in persons with tan or brown eye color and was 2.25 in persons with green or hazel eye color, indicating This table reports data for newly identified vitiligo susceptibility loci that had P < 1 × 10 −4 in the GWAS meta-analysis (GWAS1 + GWAS2), P < 0.05 in the replication study and P < 5 × 10 −8 in the overall meta-analysis (GWAS1 + GWAS2 + replication study), with consistent effect allele and nonsignificant Breslow-Day heterogeneity statistics for the ORs across all three studies (P > 1.09 × 10 −3 ). Chr., chromosome; RA, reference allele; EA, effect allele; EAF, effect allele frequency (among all cases and controls).
As shown in
a Imputed from 1000 Genomes Project data. b The association signal at 19p13.3 does not quite achieve the criterion for genome-wide significance but is included for completeness. l e t t e r s npg l e t t e r s that additional eye color genes besides OCA2 constitute risk loci for vitiligo, and, indeed, TYR is associated both with vitiligo 3 and with green or hazel eye color 19 . At chromosome 16q24.3, the meta-analysis of the GWAS1 and GWAS2 data showed association of SNPs spanning nt 89,647,951-90,078,022 ( Supplementary Fig. 3a) ; the overall meta-analysis showed P = 1.82 × 10 −13 and OR= 0.79 for rs9926296 in this region. The associated region contains 20 genes, including MC1R, which encodes the melanocortin receptor, a regulator of melanogenesis and minor vitiligo autoantigen, and which is genetically associated with malignant melanoma and with skin and hair color 20 .
At 11q21, the meta-analysis of the GWAS1 and GWAS2 data showed an association with rs4409785 (nt 95,311,422) ( Supplementary  Fig. 3b ), and the overall meta-analysis showed P = 1.57 × 10 −13 and OR = 1.34 at this SNP. This and other associated SNPs in this region are located in a 559-kb segment that contains no known genes and is located approximately 6.28 Mb distal to TYR. These SNPs are not in linkage disequilibrium with TYR SNPs (r 2 = 0) and remained highly significant when conditioned on the common causal TYR SNPs rs1042602 and rs1126809. We speculate that this region might harbor a long-range regulatory element affecting TYR transcription in cis.
Besides OCA2, MC1R and the chromosome 11q21 locus, most of the loci that are associated with vitiligo encode immunoregulatory proteins. At chromosome 2q24.2, the meta-analysis of the GWAS1 and GWAS2 data showed an association with SNPs spanning nt 163,076,146-163,154,363 that are within and downstream of IFIH1 ( Supplementary Fig. 3c) ; the overall meta-analysis showed P = 4.91 × 10 −15 and OR = 0.77 for rs2111485 in this region. IFIH1 encodes an interferon-induced RNA helicase that is involved in antiviral innate immune responses 21 and is associated with type 1 diabetes 22 , Graves' disease 23 , multiple sclerosis 24 , psoriasis 25 and, perhaps, lupus 26 .
At 3q13.33, the meta-analysis of the GWAS1 and GWAS2 data showed suggestive association of SNPs (nt 119,276,377-119,197,379) spanning and upstream of CD80 (Supplementary Fig. 3d) ; the overall meta-analysis showed P = 3.78 × 10 −10 and OR = 1.34 for rs59374417 in this region. CD80 is a surface protein on activated B cells, monocytes and dendritic cells that co-stimulates T cell priming 27, 28 .
At 4p16.1, the meta-analysis of the GWAS1 and GWAS2 data showed suggestive association of SNPs (nt 10,702,156-10,729,386) upstream of CLNK (Supplementary Fig. 3e) ; the overall meta-analysis showed P = 1.56 × 10 −8 and OR = 1.21 for rs16872571 in this region. CLNK encodes the mast cell immunoreceptor signal transducer, which is a positive regulator of immunoreceptor signaling 29 .
At 6q15, the meta-analysis of the GWAS1 and GWAS2 data showed suggestive association of SNPs (nt 90,941,239-91,915,693) spanning BACH2 (Supplementary Fig. 3f) ; the overall metaanalysis showed P = 2.53 × 10 −8 and OR = 1.20 for rs3757247 in this region. BACH2 encodes a transcriptional repressor of B cells 30 and is associated with type 1 diabetes 31, 32 , celiac disease 33 and Crohn's disease 34 .
At 8q24.22, the meta-analysis of the GWAS1 and GWAS2 data showed suggestive association of SNPs (nt 133,929,917-133,979,872) spanning the TG-SLA locus, at which the two genes are interdigitated and encoded on the opposite strands ( Supplementary  Fig. 3g) ; the overall meta-analysis showed P = 1.58 × 10 −8 and OR = 1.20 for rs853308 in this region. TG encodes thyroglobulin, and SLA encodes Src-like adaptor protein, a regulator of antigen receptor signaling 35 . TG is associated with autoimmune thyroid disease 36 , which affects approximately 17% of individuals with vitiligo 2 , suggesting that the association of rs853308 with vitiligo might derive from patients with concomitant autoimmune thyroid disease. However, stratification of the data showed that the association of rs853308 with vitiligo derives both from patients with (P = 2.43 × 10 −3 ) and without (P = 3.98 × 10 −7 ) autoimmune thyroid disease, with virtually identical ORs in the two subgroups (1.20 and 1.19, respectively). Moreover, directly comparing rs853308 in patients with vitiligo with (n = 608) or without (n = 2,579) concomitant autoimmune thyroid disease showed no difference (P = 0.94, OR = 1.01). It is not apparent what role thyroglobulin might have in vitiligo pathogenesis, suggesting that the association of vitiligo with the TG-SLA locus may derive from SLA rather than TG. SLA might likewise account for the reported association of TG with autoimmune thyroid disease 36 .
At 10q25.3, the meta-analysis of the GWAS1 and GWAS2 data showed suggestive association of SNPs (nt 115,439,530-115,492,092) spanning CASP7 (Supplementary Fig. 3h) ; the overall meta-analysis showed P = 3.56 × 10 −8 and OR = 0.81 for rs3814231 in this region. CASP7 encodes caspase 7, an executioner protein of apoptosis and inflammation 37 , is associated with rheumatoid arthritis 38 and has been suggested as a positional candidate gene for IDDM17 in type 1 diabetes 39 .
At 11p13, the meta-analysis of the GWAS1 and GWAS2 data showed association of SNPs (nt 35,242,907-35,375,280) spanning portions of CD44 and SLC1A2 (Supplementary Fig. 3i) ; the overall meta-analysis showed P = 1.78 × 10 −9 and OR = 1.21 for rs10768122 in this region. CD44 encodes a cell surface glycoprotein with various functions, including a role in T cell development 40 , and is associated with lupus 41 .
At 12q13.2, the meta-analysis of the GWAS1 and GWAS2 data showed association with SNPs (nt 56,369,506-56,535,251) in a region that includes IKZF4 (Supplementary Fig. 3j) ; the overall metaanalysis showed P = 2.75 × 10 −14 and OR = 1.29 for rs2456973 in this region. IKZF4 encodes a regulator of T cell activation 42 and is associated with type 1 diabetes 43 and alopecia areata 44 .
At 12q24.12, the meta-analysis of the GWAS1 and GWAS2 data showed association with SNPs (nt 111,708,458-112,906,415) within and near SH2B3 and ATXN2 (Supplementary Fig. 3k) ; the overall meta-analysis showed P = 3.54 × 10 −18 and OR = 0.76 for rs4766578 in this region. Many SNPs in this region achieved genome-wide significance, but a logistic regression analysis indicated that they all reflect a single association signal. ATXN encodes ataxin-2 and is causal for spinocerebellar ataxia type 2. SH2B3 encodes adaptor protein LNK, which regulates the development of both B and T cells 45 , and is associated with type 1 diabetes 46 , celiac disease 47 , rheumatoid arthritis 48 , multiple sclerosis 49 and, perhaps, lupus 25 . SH2B3 therefore seems more likely to be relevant to vitiligo susceptibility than ATXN2. P values were obtained using a χ 2 distribution comparison of the number of individuals with tan or brown, green or hazel and blue or gray eyes between the patients with vitiligo and the indicated healthy groups. a The P values listed are for the comparison of the two groups between which the value is listed.
npg l e t t e r s At 22q13.2, the meta-analysis of the GWAS1 and GWAS2 data showed suggestive association with SNPs in a broad region (nt 41,707,054-42,062,822) ( Supplementary Fig. 3l) ; the overall meta-analysis showed P = 6.81 × 10 −10 and OR = 0.78 for rs4822024 in this region. The region of association contains 12 genes, including TOB2, which encodes a regulator of cell cycle progression that is involved in T cell tolerance 50 , although assignment of TOB2 as causal remains uncertain.
Besides these 13 newly identified vitiligo susceptibility loci, we note an additional suggestive association at 19p13.3 that did not achieve genome-wide significance. The meta-analysis of the GWAS1 and GWAS2 data showed a suggestive association of SNPs (nt 4,830,628-4,837,557) spanning TICAM1 (Supplementary Fig. 3m ) that achieved near significance in the overall meta-analysis (rs6510827, P = 8.80 × 10 −8 , OR = 1. 19) . TICAM1 encodes toll-like receptor adaptor molecule 1, which mediates innate immune responses to viral pathogens 51 . SNPs at ten additional loci that appeared suggestive in the meta-analysis of the GWAS1 and GWAS2 data were not confirmed by the replication study (Supplementary Table 3) .
Altogether, the vitiligo susceptibility loci we identified account for approximately 10% of vitiligo risk in individuals of European ancestry and about 18% of the vitiligo heritability in these individuals (h 2 ~ 0.75). Most of the genes in these loci encode immunoregulatory or melanocyte proteins that likely mediate the antigenic triggering and immune targeting of melanocytes, and a bioinformatic network analysis indicated at least 26 of these comprise a functional network spanning from the melanocyte to the immune system (Supplementary Fig. 4) . Many vitiligo susceptibility genes are shared with other autoimmune diseases, usually sharing the same high-risk alleles, which is consistent with observed epidemiological associations among these diseases (Supplementary Fig. 5) . A functional prediction of all genotyped and imputed missense and splice junction variants in all confirmed non-MHC vitiligo loci ( Supplementary Table 4 ) identified predicted deleterious variants at PTPN22, IFIH1, SLA, CD44, TYR, OCA2, MC1R, UBASH3A and C1QTNF6, and at TYR two common variants, p.Ser192Tyr and p.Arg402Gln, confer protection from vitiligo, whereas HLA-A*02:01 confers risk 6 . Although there are probably additional unidentified vitiligo susceptibility loci, the loci and candidate genes already identified provide insights into vitiligo pathobiology, the optimal use of existing therapies and even new approaches to treatment. 
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Methods and any associated references are available in the online version of the paper.
oNLINe MeThodS
Subjects. GWAS1 has been described previously 3 . GWAS2 included 450 unrelated patients with generalized vitiligo (cases) of non-Hispanic and non-Latino European ancestry (EUR) from North America and Europe who met strict clinical criteria for generalized vitiligo 52 . The controls for GWAS2 were 3,182 EUR individuals not specifically known to have any autoimmune disease or malignant melanoma for whom genome-wide genotypes were obtained from the NCBI database of Genotypes and Phenotypes (dbGaP; phs000092.v1.p1, phs000125.v1.p1, phs000138.v2.p1, phs000168.v1.p1 and phs000206.v3.p2) or from the Illumina iControlDB. The replication study included 1,440 unrelated EUR cases with generalized vitiligo and 1,316 unrelated EUR controls from North America and Europe, principally spouses of patients with vitiligo from the GWAS2 study and the replication study itself. There was no overlap of cases and controls between the GWAS1, GWAS2 and replication cohorts. Cases and controls provided clinical history regarding vitiligo and other autoimmune diseases, as has been described previously for GWAS1 (ref. 3) , and controls having known relatives with vitiligo or reporting any known autoimmune diseases or melanoma were excluded. Eye color was determined by self-report. Written informed consent was obtained from all study subjects. This study was approved by the institutional review boards of each participating institution and was conducted according to Declaration of Helsinki principles.
Genotyping and quality control. Genomic DNA was prepared from saliva specimens using a DNA self-collection kit according to the manufacturer's instructions (Oragene, DNA Genotek). For genome-wide genotyping, DNA concentrations were assayed using both fluorescence staining (PicoGreen method, Invitrogen) and ultraviolet A260 spectrophotometry (Nanodrop, Thermo Scientific). For genotyping specific SNPs in the replication study, DNA concentrations were assayed by Nanodrop.
Genome-wide genotyping for the GWAS2 cases was performed for 657,366 SNPs using Illumina Human660W-Quad BeadChips according to the manufacturer's instructions. GWAS2 controls obtained from the dbGaP and Illumina iControlDB databases had been genotyped using Illumina Human 610-Quad and Human 1Mv1 BeadChips. Genotyping of 46 SNPs in the replication study was performed using a custom Illumina GoldenGate assay according to the manufacturer's instructions.
Quality control filtering of genome-wide genotype data in GWAS2 was carried out as described for GWAS1 (ref.
3) using Illumina GenomeStudio, version 3, and PLINK 53 , version 1.07. Cases were excluded on the basis of SNP call rates <98.5% (n = 16), discordance between reported and observed sex (n = 0) and/or inadvertent subject duplication (n = 0). Beyond prior quality control procedures, controls were excluded on the basis of SNP call rates <95% (n = 0). Additional cases (n = 6) and controls (n = 356) were excluded on the basis of cryptic relatedness based on pairwise identity-by-descent estimations (pi-hat > 0.05) of the entire (GWAS1 + GWAS2) summary dataset, in which case the individual with lower SNP call rate was excluded. SNPs were excluded on the basis of genotype missing rate ≥2% overall (n = 97,301) in cases plus controls, observed minor allele frequency <0.01 (n = 23,064), significant deviation (P < 10 −5 ) from Hardy-Weinberg equilibrium in the control dataset (n = 5,241) and/or significant difference (P < 10 −5 ) in the genotype missing rate in cases compared to controls (n = 35,939). Data for SNPs with P < 10 −15 were reviewed with respect to genotype clusters and allele calls in cases and minor allele frequency in controls compared to the data in public data sources and were excluded if there were apparent data quality problems (n = 2). To control for population stratification, we performed a principal components analysis using EIGENSOFT 54 , version 4.2, and excluded as outliers cases (n = 10) and controls (n = 16) whose ancestry was at least six standard deviations from the mean on one of the top ten eigenvectors.
In the replication study, we successfully determined genotypes for 46 SNPs that showed suggestive (P < 10 −4 ) or significant P values in the genome-wide meta-analysis of the GWAS1 and GWAS2 data using a custom Illumina GoldenGate assay. SNP genotypes were subjected to quality control filters similar to those in GWAS1 and GWAS2, as appropriate.
Statistical analyses. For GWAS2, after quality control filtering of subjects and SNP data and the removal of genetic outliers, we compared the allele frequencies of the remaining 495,821 SNPs in the final 418 cases and 2,810 controls using the unadjusted Cochran-Armitage trend test implemented in PLINK 53 and the adjusted Cochran-Armitage trend test implemented in EIGENSOFT 54 , in which both the phenotypes and genotypes of the subjects were adjusted for ancestry using the top ten eigenvectors. The unadjusted Cochran-Armitage trend tests and the adjusted Cochran-Armitage trend tests yielded genomic inflation factors of 1.054 and 1.050, respectively, indicating that the residual population stratification was negligible. ORs and 95% confidence limits were calculated by logistic regression analysis using PLINK 53 .
To fully assess associations at the 24 newly identified suggestive loci, we imputed genotypes for each locus using MACH 55 , version 1.0 based on patterns of haplotype variation in the 1000 Genomes Project European ancestry samples (August 4, 2010 release). We retained imputed SNPs with r 2 > 0.3 and minor allele frequency >0.01 for further analyses.
For the replication study, after quality control filtering, we compared the allele frequencies for the genotyped SNPs in the remaining 1,377 cases and 1,284 controls using the Cochran-Armitage trend test. ORs and 95% confidence limits were calculated by logistic regression analysis.
To obtain combined ORs and P values for the GWAS1 and GWAS2 data and for the combined GWAS1, GWAS2 and replication studies, we performed a meta-analysis using a Cochran-Mantel-Haenszel test. A Breslow-Day test was used to test for heterogeneity of the ORs of the same SNP in different study cohorts.
The calculation of linkage disequilibrium between SNPs in regions of association was carried out using Haploview 56 , version 4.2. As a test of the independent effect of a given locus conditioned on the effect of another locus, we compared the fit of a model containing both loci to a model containing only the conditioning locus, assuming a multiplicative genotypic effect for the high-risk allele of each locus. Analyses were performed using STATA, version 10.0.
We estimated the contribution of known vitiligo susceptibility loci to the total variance in vitiligo liability as the difference between the variance accounted for by all SNPs genome-wide and the variance remaining after removing SNPs in known vitiligo susceptibility loci using GCTA 57 to estimate the two components of variance. We estimated the heritability of vitiligo liability 58 
Functional network analysis.
To gain insights into the potential functional relationships among candidate genes located within vitiligo susceptibility loci, we carried out a functional interaction network analysis using the Search Tool for the Retrieval of Interacting Genes (STRING) 9.0 (ref. 61 ). The input data were all known vitiligo susceptibility loci (including TICAM1 and the selection of BTNL2 to represent the MHC class II gene region 3 ). In addition, we iteratively tested the inclusion of all proteins encoded by genes in the 16q24.3 and 22q13.2 association regions, as well as FAM76B, as potentially representing the 11q21 association region as a means of possible gene identification.
